Published in F1000Res on July 18, 2017
The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ (2009) 8.17
Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index. Lancet (2012) 6.33
The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med (1996) 5.52
Choice of primary outcomes in randomised trials and systematic reviews evaluating interventions for preterm birth prevention: a systematic review. BJOG (2014) 4.13
Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data. BMC Pregnancy Childbirth (2010) 3.89
Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial. Lancet (2016) 3.53
Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol (2003) 3.36
Provision and practice of specialist preterm labour clinics: a UK survey of practice. BJOG (2013) 2.70
Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur J Neurosci (2008) 2.65
Preterm labor: one syndrome, many causes. Science (2014) 2.61
Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol (2013) 2.55
Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG (2009) 2.38
Patients with an ultrasonographic cervical length < or =15 mm have nearly a 50% risk of early spontaneous preterm delivery. Am J Obstet Gynecol (2000) 2.21
Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ (2004) 1.92
Ureaplasma species: role in neonatal morbidities and outcomes. Arch Dis Child Fetal Neonatal Ed (2013) 1.64
Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection. J Matern Fetal Neonatal Med (2007) 1.62
Diversity of microbes in amniotic fluid. Semin Fetal Neonatal Med (2011) 1.58
Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol (1998) 1.52
Cost-effectiveness of screening and treatment for bacterial vaginosis in early pregnancy among women at low risk for preterm birth. Acta Obstet Gynecol Scand (2004) 1.48
In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microbiol Infect (2010) 1.42
Cervical Pessary and Vaginal Progesterone in Twin Pregnancies With a Short Cervix. Obstet Gynecol (2016) 1.40
Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes. Curr Opin Infect Dis (2013) 1.33
Prediction of risk for preterm delivery by ultrasonographic measurement of cervical length. Am J Obstet Gynecol (1990) 1.32
Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol (2015) 1.16
The West Los Angeles Preterm Birth Prevention Project. I. Program impact on high-risk women. Am J Obstet Gynecol (1994) 1.12
Infection-induced inflammation and cerebral injury in preterm infants. Lancet Infect Dis (2014) 1.10
Intraamniotic infection with genital mycoplasmas exhibits a more intense inflammatory response than intraamniotic infection with other microorganisms in patients with preterm premature rupture of membranes. Am J Obstet Gynecol (2010) 1.06
The bacterial load of Ureaplasma parvum in amniotic fluid is correlated with an increased intrauterine inflammatory response. Diagn Microbiol Infect Dis (2010) 1.05
Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Reprod Immunol (2014) 1.04
Risks of statin use during pregnancy: a systematic review. J Obstet Gynaecol Can (2007) 1.02
Mycoplasma, bacterial vaginosis-associated bacteria BVAB3, race, and risk of preterm birth in a high-risk cohort. Am J Obstet Gynecol (2013) 0.99
Neonatal morbidity associated with late preterm and early term birth: the roles of gestational age and biological determinants of preterm birth. Int J Epidemiol (2013) 0.97
Amnionitis with Ureaplasma urealyticum or other microbes leads to increased morbidity and prolonged hospitalization in very low birth weight infants. Eur J Obstet Gynecol Reprod Biol (2006) 0.97
Is universal cervical length screening indicated in women with prior term birth? Am J Obstet Gynecol (2014) 0.95
Antimicrobial susceptibility patterns of Ureaplasma species and Mycoplasma hominis in pregnant women. BMC Infect Dis (2014) 0.93
Preterm birth, intrauterine infection, and fetal inflammation. Front Immunol (2014) 0.91
A Core Outcome Set for Evaluation of Interventions to Prevent Preterm Birth. Obstet Gynecol (2016) 0.91
Strategies to prevent preterm birth. Front Immunol (2014) 0.91
Whole blood gene expression profile associated with spontaneous preterm birth in women with threatened preterm labor. PLoS One (2014) 0.90
Bacterial aetiological agents of intra-amniotic infections and preterm birth in pregnant women. Front Cell Infect Microbiol (2013) 0.90
Specialised antenatal clinics for women with a pregnancy at high risk of preterm birth (excluding multiple pregnancy) to improve maternal and infant outcomes. Cochrane Database Syst Rev (2011) 0.90
Pharmacological inhibition of inflammatory pathways for the prevention of preterm birth. J Reprod Immunol (2011) 0.90
Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance. Am J Obstet Gynecol (2015) 0.89
Outcomes in preterm infants. Public Health (2014) 0.89
Prevention of preterm birth: harnessing science to address the global epidemic. Sci Transl Med (2014) 0.88
Treatment of bacterial vaginosis: what we have and what we miss. Expert Opin Pharmacother (2014) 0.88
Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Ultrasound Obstet Gynecol (2016) 0.87
Neonatal Outcomes of Very Low Birth Weight and Very Preterm Neonates: An International Comparison. J Pediatr (2016) 0.87
Chorioamnionitis-induced fetal gut injury is mediated by direct gut exposure of inflammatory mediators or by lung inflammation. Am J Physiol Gastrointest Liver Physiol (2014) 0.86
Comparison of placental pathology in preterm, late-preterm, near-term, and term births. Am J Obstet Gynecol (2013) 0.86
Outcomes for extremely premature infants. Anesth Analg (2015) 0.86
Probiotics in the prevention of recurrences of bacterial vaginosis. Altern Ther Health Med (2014) 0.85
Pregnancy outcomes in a recurrent preterm birth prevention clinic. Am J Obstet Gynecol (2011) 0.85
The effect of second-trimester antibiotic therapy on the rate of preterm birth. J Obstet Gynaecol Can (2007) 0.85
Routine Use of an Antenatal Infection Screen-and-Treat Program to Prevent Preterm Birth: Long-Term Experience at a Tertiary Referral Center. Birth (2015) 0.84
Development of a novel noncompetitive antagonist of IL-1 receptor. J Immunol (2008) 0.84
Chorioamniotic membrane senescence: a signal for parturition? Am J Obstet Gynecol (2015) 0.84
Low-dose aspirin and preterm birth: a randomized controlled trial. Obstet Gynecol (2015) 0.84
The role of Mycoplasma and Ureaplasma in adverse pregnancy outcomes. Obstet Gynecol Clin North Am (2014) 0.83
Why Do Women Not Use Preconception Care? A Systematic Review On Barriers And Facilitators. Obstet Gynecol Surv (2016) 0.83
Reducing the rate of preterm birth through a simple antenatal screen-and-treat programme: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol (2010) 0.83
Cost-effectiveness of risk-based screening for cervical length to prevent preterm birth. Am J Obstet Gynecol (2016) 0.83
Novel Noncompetitive IL-1 Receptor-Biased Ligand Prevents Infection- and Inflammation-Induced Preterm Birth. J Immunol (2015) 0.82
HSP60 is involved in the neuroprotective effects of naloxone. Mol Med Rep (2014) 0.81
Prevention of preterm delivery: current challenges and future prospects. Int J Womens Health (2016) 0.81
Cost effectiveness of a screen-and-treat program for asymptomatic vaginal infections in pregnancy: towards a significant reduction in the costs of prematurity. Eur J Obstet Gynecol Reprod Biol (2005) 0.81
Progesterone receptors and neural development: a gap between bench and bedside? Endocrinology (2008) 0.81
Can statins reduce the inflammatory response associated with preterm birth in an animal model? Am J Obstet Gynecol (2012) 0.81
Statins prevent cervical remodeling, myometrial contractions and preterm labor through a mechanism that involves hemoxygenase-1 and complement inhibition. Mol Hum Reprod (2014) 0.81
The fetal safety of statins: a systematic review and meta-analysis. J Obstet Gynaecol Can (2014) 0.81
Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis. J Obstet Gynaecol Can (2015) 0.81
A universal mid-trimester transvaginal cervical length screening program and its associated reduced preterm birth rate. Am J Obstet Gynecol (2016) 0.81
Inflammation-induced sensitization of the brain in term infants. Dev Med Child Neurol (2015) 0.80
Universal cervical length screening: implementation and outcomes. Am J Obstet Gynecol (2016) 0.80
Sterile inflammation and pregnancy complications: a review. Reproduction (2016) 0.80
Global burden of prematurity. Semin Fetal Neonatal Med (2015) 0.80
Cost-effectiveness of transabdominal ultrasound for cervical length screening for preterm birth prevention. Am J Obstet Gynecol (2013) 0.80
Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice. Am J Obstet Gynecol (2013) 0.80
Vaginal progesterone, but not 17α-hydroxyprogesterone caproate, has antiinflammatory effects at the murine maternal-fetal interface. Am J Obstet Gynecol (2015) 0.79
Can statins prevent pregnancy complications? J Reprod Immunol (2013) 0.79
Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: An updated meta-analysis of individual patient data. Ultrasound Obstet Gynecol (2017) 0.78
Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update. Am J Obstet Gynecol (2015) 0.78
Effect of Modifiable Risk Factors on Preterm Birth: A Population Based-Cohort. Matern Child Health J (2017) 0.78
Drugs to block cytokine signaling for the prevention and treatment of inflammation-induced preterm birth. Front Immunol (2015) 0.78
Crosstalk between monocytes and myometrial smooth muscle in culture generates synergistic pro-inflammatory cytokine production and enhances myocyte contraction, with effects opposed by progesterone. Mol Hum Reprod (2015) 0.78
Intra-amniotic pharmacological blockade of inflammatory signalling pathways in an ovine chorioamnionitis model. Mol Hum Reprod (2015) 0.78
Placental Infection With Ureaplasma species Is Associated With Histologic Chorioamnionitis and Adverse Outcomes in Moderately Preterm and Late-Preterm Infants. J Infect Dis (2015) 0.78
Probiotics in obstetrics and gynaecology. Aust N Z J Obstet Gynaecol (2015) 0.77
Antiplatelet Agents and the Prevention of Spontaneous Preterm Birth: A Systematic Review and Meta-analysis. Obstet Gynecol (2017) 0.77
The treatment of bacterial vaginosis in pregnancy with clindamycin to reduce the risk of infection-related preterm birth: a response to the Danish Society of Obstetrics and Gynaecology guideline group's clinical recommendations. Acta Obstet Gynecol Scand (2016) 0.77
Naloxone alters organ perfusion during endotoxin shock in conscious rats. Am J Physiol (1988) 0.77
Cervical elastography during pregnancy: a critical review of current approaches with a focus on controversies and limitations. J Med Ultrason (2001) (2016) 0.77
Toll-Like Receptor 4 Is an Essential Upstream Regulator of On-Time Parturition and Perinatal Viability in Mice. Endocrinology (2015) 0.77
Fetal fibronectin versus cervical length as predictors of preterm birth in twin pregnancy with or without 17-hydroxyprogesterone caproate. Am J Perinatol (2014) 0.77
A critical role of interleukin-1 in preterm labor. Cytokine Growth Factor Rev (2015) 0.77
The CROWN initiative: journal editors invite researchers to develop core outcomes in women's health. BMC Pregnancy Childbirth (2014) 0.77
Effectiveness of progesterone, cerclage and pessary for preventing preterm birth in singleton pregnancies: a systematic review and network meta-analysis. BJOG (2017) 0.77
Variability in diagnosis of clue cells, lactobacillary grading and white blood cells in vaginal wet smears with conventional bright light and phase contrast microscopy. Eur J Obstet Gynecol Reprod Biol (2009) 0.77
A randomized controlled trial of intramuscular versus vaginal progesterone for the prevention of recurrent preterm birth. Int J Gynaecol Obstet (2016) 0.76
Universal cervical length screening for singleton pregnancies with no history of preterm delivery, or the inverse of the Pareto principle. BJOG (2016) 0.76